Ultragenyx Pharmaceutical | 営業利益

株価
22.92
毎日の変更
0.17 0.75%
毎月
-5.72%
毎年
-44.93%
Q1 予測
22.02




営業利益 変化する 日付
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Immunic USD -25.73M 2.91M 2024-09
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Kyowa Hakko Kirin JPY 38.35B 12.49B 2025-12
MacroGenics USD 18.64M 55.4M 2025-09
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xoma USD -15.64M 5.56M 2024-09


Ultragenyx Pharmaceutical 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.